Calico(CRC)
Focus: Calico is a publicly-traded biotechnology company headquartered in Long Beach, CA, specializing in aging treatments with a diversified pipeline across oncology, cardiovascular, and infectious disease indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
22+22 this month
Hot — 23 jobs added in 30d
Net +22 (23 new, 1 removed). Aggressive expansion phase.
Should You Work at Calico?
AI assessmentCalico offers financial stability and diverse scientific problems for established pharma professionals, but severely limited hiring velocity makes entry challenging.
Why Work Here
- Public company with $2.8B revenue (FY2025) and $564M net income provides financial stability and career visibility
- Diverse pipeline of 22 programs across multiple therapeutic areas including oncology and neurodegenerative disease creates breadth of opportunity
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$2.8B
Pipeline & Clinical Trials
DRUG: ABBV-CLS-484
Advanced Solid Tumor CancerClinical Trials (1)
NCT06188975Expanded Access to ABBV-CLS-484
N/AHelp build intelligence for Calico
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.